1,865
Views
0
CrossRef citations to date
0
Altmetric
Review Article

The Effects of Spirulina Supplementation on Cardiometabolic Risk Factors: A Narrative Review

, MSc, , PhD, , MSc, PhD &

References

  • Alam A, Siddiqui M, Quamri A, Fatima S, Roqaiya M, Ahmad Z. 2016. Efficacy of Spirulina (Tahlab) in patients of type 2 diabetes mellitus (Ziabetus Shakri): a randomized controlled trial. J Diabetes Metab. 7(10):1–5. doi:10.4172/2155-6156.1000710.
  • Al-Dhabi NA. 2013. Heavy metal analysis in commercial Spirulina products for human consumption. Saudi J Biol Sci. 20(4):383–388. doi:10.1016/j.sjbs.2013.04.006.
  • Babadzhanov A, Abdusamatova N, Yusupova F, Faizullaeva N, Mezhlumyan L, Malikova MK. 2004. Chemical composition of spirulina platensis cultivated in Uzbekistan. Chem Nat Compd. 40(3):276–279. doi:10.1023/B:CONC.0000039141.98247.e8.
  • Beihaghi M, Ghodrati Azadi H, Taherzadeh Z, Bahrami H. r 2017. The effects of oral administration of spirulina platensis (cultured Iranian) on blood glucose and glycosylated hemoglobin blood in type ii diabetes mellitus patients. Iran J Diabetes Lipid Disord. 16(3):183–190. http://ijdld.tums.ac.ir/article-1-5520-en.html.
  • Belay A. 2007. Spirulina (Arthrospira): production and quality assurance. In: Amha Belay, editor. Spirulina in human nutrition and health. CRC Press; p. 15–40. https://www.taylorfrancis.com/chapters/edit/10 .1201/9781420052572-4/spirulina-arthrospira-production-quality-assurance-amha-belay
  • Billington CK, Ojo OO, Penn RB, Ito S. 2013. cAMP regulation of airway smooth muscle function. Pulm Pharmacol Ther. 26(1):112–120. doi:10.1016/j.pupt.2012.05.007.
  • Bobescu E, Bălan A, Moga MA, Teodorescu A, Mitrică M, Dima L. 2020. Are there any beneficial effects of spirulina supplementation for metabolic syndrome components in postmenopausal women? Mar Drugs. 18(12):651. doi:10.3390/md18120651.
  • Capelli B, Cysewski GR. 2010. Potential health benefits of spirulina microalgae* A review of the existing literature. Nutrafoods. 9(2):19–26. doi:10.1007/BF03223332.
  • Costa JAV, Freitas BCB, Rosa GM, Moraes L, Morais MG, Mitchell BG. 2019. Operational and economic aspects of Spirulina-based biorefinery. Bioresour Technol. 292:121946. doi:10.1016/j.biortech.2019.121946.
  • D’Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. 2008. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 117(6):743–753. doi:10.1161/CIRCULATIONAHA.107.699579.
  • Demir BS, Tükel SS. 2010. Purification and characterization of lipase from Spirulina platensis. J Mol Catal B: Enzym. 64(3–4):123–128. doi:10.1016/j.molcatb.2009.09.011.
  • Drozdz D, Alvarez-Pitti J, Wójcik M, Borghi C, Gabbianelli R, Mazur A, Herceg-Čavrak V, Lopez-Valcarcel BG, Brzeziński M, Lurbe E, et al. 2021. Obesity and cardiometabolic risk factors: from childhood to adulthood. Nutrients. 13(11):4176. doi:10.3390/nu13114176.
  • Estrada JP, Bescós PB, Del Fresno AV. 2001. Antioxidant activity of different fractions of Spirulina platensis protean extract. Il Farmaco. 56(5–7):497–500.
  • Fujimoto M, Tsuneyama K, Fujimoto T, Selmi C, Gershwin ME, Shimada Y. 2012. Spirulina improves non-alcoholic steatohepatitis, visceral fat macrophage aggregation, and serum leptin in a mouse model of metabolic syndrome. Dig Liver Dis. 44(9):767–774. doi:10.1016/j.dld.2012.02.002.
  • Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I. 2017. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 114(12):1752–1761. doi:10.1172/JCI21625.
  • Graille M, Wild P, Sauvain JJ, Hemmendinger M, Guseva Canu I, Hopf NB. 2020. Urinary 8-isoprostane as a biomarker for oxidative stress. A systematic review and meta-analysis. Toxicol Lett. 328:19–27. doi:10.1016/j.toxlet.2020.04.006.
  • Guo W, Zeng M, Zhu S, Li S, Qian Y, Wu H. 2022. Phycocyanin ameliorates mouse colitis via phycocyanobilin-dependent antioxidant and anti-inflammatory protection of the intestinal epithelial barrier. Food Funct. 13(6):3294–3307. doi:10.1039/d1fo02970c.
  • Han L-K, Li D-X, Xiang L, Gong X-J, Kondo Y, Suzuki I, Okuda H. 2006. Isolation of pancreatic lipase activity-inhibitory component of Spirulina platensis and it reduce postprandial triacylglycerolemia. Yakugaku Zasshi. 126(1):43–49. doi:10.1248/yakushi.126.43.
  • Hernández-Lepe MA, López-Díaz JA, Juárez-Oropeza MA, Hernández-Torres RP, Wall-Medrano A, Ramos-Jiménez A. 2018. Effect of Arthrospira (Spirulina) maxima supplementation and a systematic physical exercise program on the body composition and cardiorespiratory fitness of overweight or obese subjects: a double-blind, randomized, and crossover controlled trial. Mar Drugs. 16(10):364. doi:10.3390/md16100364.
  • Hindy G, Engström G, Larsson SC, Traylor M, Markus HS, Melander O, Orho-Melander M. 2018. Role of blood lipids in the development of ischemic stroke and its subtypes: a Mendelian randomization study. Stroke. 49(4):820–827. doi:10.1161/STROKEAHA.117.019653.
  • Holmes MV, Asselbergs FW, Palmer TM, Drenos F, Lanktree MB, Nelson CP, Dale CE, Padmanabhan S, Finan C, Swerdlow DI, et al. 2015. Mendelian randomization of blood lipids for coronary heart disease. Eur Heart J. 36(9):539–550. doi:10.1093/eurheartj/eht571.
  • Hornych A, Oravec S, Girault F, Forette B, Horrobin D. 2002. The effect of gamma-linolenic acid on plasma and membrane lipids and renal prostaglandin synthesis in older subjects. Bratisl Lek Listy. 103(3):101–107.
  • Horrobin D. 1992. Nutritional and medical importance of gamma-linolenic acid. Prog Lipid Res. 31(2):163–194. doi:10.1016/0163-7827(92)90008-7.
  • Ionov VA, Basova MM. 2003. Use of blue-green micro-seaweed Spirulina platensis for the correction of lipid and hemostatic disturbances in patients with ischemic heart disease. Vopr Pitan. 72(6):28–31. https://www.scopus.com/inward/record.uri?eid=2-s2.0-2942679819&partnerID=40&md5=984f5c6983e5a80afe5a38354aad1b38.
  • Iyer Uma M, Sophia A, Uliyar V. 1999. Glycemic and lipemic responses of selected spirulina-supplemented rice-based recipes in normal subjects. Age Years. 22:1–8.
  • Karizi SR, Armanmehr F, Azadi HG, Zahroodi HS, Ghalibaf AM, Bazzaz BSF, Abbaspour M, Boskabadi J, Eslami S, Taherzadeh Z. 2023. A randomized, double-blind placebo-controlled add-on trial to assess the efficacy, safety, and anti-atherogenic effect of spirulina platensis in patients with inadequately controlled type 2 diabetes mellitus. Phytother Res. 37(4):1435–1448. doi:10.1002/ptr.7674.
  • Karkos PD, Leong SC, Karkos CD, Sivaji N, Assimakopoulos DA. 2011. Spirulina in clinical practice: evidence-based human applications. Evid Based Complement Alternat Med. 2011:531053–531054. doi:10.1093/ecam/nen058.
  • Kennedy DO. 2016. B vitamins and the brain: mechanisms, dose and efficacy—a review. Nutrients. 8(2):68. doi:10.3390/nu8020068.
  • Koite NDLN, Sanogo NgI, Lépine O, Bard J-M, Ouguerram K. 2022. Antioxidant efficacy of a spirulina liquid extract on oxidative stress status and metabolic disturbances in subjects with metabolic syndrome. Mar Drugs. 20(7):441. doi:10.3390/md20070441.
  • Kulshreshtha A, Zacharia AJ, Jarouliya U, Bhadauriya P, Prasad GBKS, Bisen PS. 2008. Spirulina in health care management. Curr Pharm Biotechnol. 9(5):400–405. doi:10.2174/138920108785915111.
  • Le T-M, Knulst AC, Röckmann H. 2014. Anaphylaxis to Spirulina confirmed by skin prick test with ingredients of Spirulina tablets. Food Chem Toxicol. 74:309–310. doi:10.1016/j.fct.2014.10.024.
  • Lee EH, Park J-E, Choi Y-J, Huh K-B, Kim W-Y. 2008. A randomized study to establish the effects of spirulina in type 2 diabetes mellitus patients. Nutr Res Pract. 2(4):295–300. doi:10.4162/nrp.2008.2.4.295.
  • Liu R, Qin S, Li W. 2022. Phycocyanin: Anti-inflammatory effect and mechanism. Biomed Pharmacother. 153:113362. doi:10.1016/j.biopha.2022.113362.
  • Lu YM, Xiang WZ, Wen YH. 2011. Spirulina (Arthrospira) industry in Inner Mongolia of China: current status and prospects. J Appl Phycol. 23(2):265–269. doi:10.1007/s10811-010-9552-4.
  • Lupatini AL, Colla LM, Canan C, Colla E. 2017. Potential application of microalga Spirulina platensis as a protein source. J Sci Food Agric. 97(3):724–732. doi:10.1002/jsfa.7987.
  • Maddiboyina B, Vanamamalai HK, Roy H, Gandhi S, Kavisri M, Moovendhan M. (2023). Food and drug industry applications of microalgae Spirulina platensis: a review. J Basic Microbiol, 63(6), 573–583. doi:10.1002/jobm.202200704.
  • Mani U, Desai S, Iyer U. 2000. Studies on the long-term effect of spirulina supplementation on serum lipid profile and glycated proteins in NIDDM patients. J Nutraceuticals Funct Med Foods. 2(3):25–32. doi:10.1300/J133v02n03_03.
  • Marles RJ, Barrett ML, Barnes J, Chavez ML, Gardiner P, Ko R, Mahady GB, Low Dog T, Sarma ND, Giancaspro GI, et al. 2011. United States pharmacopeia safety evaluation of spirulina. Crit Rev Food Sci Nutr. 51(7):593–604. doi:10.1080/10408391003721719.
  • Martínez-Sámano J, Torres-Montes de Oca A, Luqueño-Bocardo OI, Torres-Durán PV, Juárez-Oropeza MA. 2018. Spirulina maxima decreases endothelial damage and oxidative stress indicators in patients with systemic arterial hypertension: Results from exploratory controlled clinical trial. Mar Drugs. 16(12):496. doi:10.3390/md16120496.
  • Masuda K, Chitundu M. 2019. Multiple micronutrient supplementation using spirulina platensis during the first 1000 days is positively associated with development in children under five years: a follow up of a randomized trial in Zambia. Nutrients. 11(4):730. doi:10.3390/nu11040730.
  • Matsuura E, Hughes GR, Khamashta MA. 2008. Oxidation of LDL and its clinical implication. Autoimmun Rev. 7(7):558–566. doi:10.1016/j.autrev.2008.04.018.
  • Mazokopakis EE, Papadomanolaki MG, Fousteris AA, Kotsiris DA, Lampadakis IM, Ganotakis ES. 2014. The hepatoprotective and hypolipidemic effects of Spirulina (Arthrospira platensis) supplementation in a Cretan population with non-alcoholic fatty liver disease: a prospective pilot study. Ann Gastroenterol. 27(4):387–394.
  • Mazokopakis EE, Starakis IK, Papadomanolaki MG, Mavroeidi NG, Ganotakis ES. 2014. The hypolipidaemic effects of Spirulina (Arthrospira platensis) supplementation in a Cretan population: a prospective study. J Sci Food Agric. 94(3):432–437. doi:10.1002/jsfa.6261.
  • Mezhal F, Oulhaj A, Abdulle A, AlJunaibi A, Alnaeemi A, Ahmad A, Leinberger-Jabari A, Al Dhaheri AS, AlZaabi E, Al-Maskari F, et al. 2023. High prevalence of cardiometabolic risk factors amongst young adults in the United Arab Emirates: the UAE healthy future study. BMC Cardiovasc Disord. 23(1):137. doi:10.1186/s12872-023-03165-3.
  • Miczke A, Szulińska M, Hansdorfer-Korzon R, Kręgielska-Narożna M, Suliburska J, Walkowiak J, Bogdański P. 2016. Effects of spirulina consumption on body weight, blood pressure, and endothelial function in overweight hypertensive Caucasians: a double-blind, placebo-controlled, randomized trial. Eur Rev Med Pharmacol Sci. 20(1):150–156.
  • Mohiti S, Zarezadeh M, Naeini F, Tutunchi H, Ostadrahimi A, Ghoreishi Z, Ebrahimi Mamaghani M. 2021. Spirulina supplementation and oxidative stress and pro-inflammatory biomarkers: A systematic review and meta-analysis of controlled clinical trials. Clin Exp Pharmacol Physiol. 48(8):1059–1069. doi:10.1111/1440-1681.13510.
  • Naeini F, Zarezadeh M, Mohiti S, Tutunchi H, Ebrahimi Mamaghani M, Ostadrahimi A. 2021. Spirulina supplementation as an adjuvant therapy in enhancement of antioxidant capacity: A systematic review and meta-analysis of controlled clinical trials. Int J Clin Pract. 75(10):e14618. doi:10.1111/ijcp.14618.
  • Nagaoka S, Shimizu K, Kaneko H, Shibayama F, Morikawa K, Kanamaru Y, Otsuka A, Hirahashi T, Kato T. 2005. A novel protein C-phycocyanin plays a crucial role in the hypocholesterolemic action of Spirulina platensis concentrate in rats. J Nutr. 135(10):2425–2430. doi:10.1093/jn/135.10.2425.
  • Panday A, Sahoo MK, Osorio D, Batra S. 2015. NADPH oxidases: an overview from structure to innate immunity-associated pathologies. Cell Mol Immunol. 12(1):5–23. doi:10.1038/cmi.2014.89.
  • Pande A, Sarkar R, Krishnamoorthi K. 1981. Toxicity of copper sulphate to the alga Spirulina platensis, & the ciliate Tetrahymena pyriformis. Indian J Exp Biol. New Delhi. 19(5):500–502.
  • Parikh P, Mani U, Iyer U. 2001. Role of Spirulina in the control of glycemia and lipidemia in type 2 diabetes mellitus. J Med Food. 4(4):193–199. doi:10.1089/10966200152744463.
  • Park HS, Park JY, Yu R. 2005. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-α and IL-6. Diabetes Res Clin Pract. 69(1):29–35. doi:10.1016/j.diabres.2004.11.007.
  • Patel RV, Mistry BM, Shinde SK, Syed R, Singh V, Shin HS. 2018. Therapeutic potential of quercetin as a cardiovascular agent. Eur J Med Chem. 155:889–904. doi:10.1016/j.ejmech.2018.06.053.
  • Piché M-E, Tchernof A, Després J-P. 2020. Obesity phenotypes, diabetes, and cardiovascular diseases. Circ Res. 126(11):1477–1500. doi:10.1161/CIRCRESAHA.120.316101.
  • Powell-Wiley TM, Poirier P, Burke LE, Després J-P, Gordon-Larsen P, Lavie CJ, Lear SA, Ndumele CE, Neeland IJ, Sanders P, et al. 2021. Obesity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 143(21):e984–e1010. doi:10.1161/CIR.0000000000000973.
  • Quagliariello V, Basilicata MG, Pepe G, De Anseris R, Di Mauro A, Scognamiglio G, Palma G, Vestuto V, Buccolo S, Luciano A, et al. 2022. Combination of Spirulina platensis, ganoderma lucidum and moringa oleifera improves cardiac functions and reduces pro-inflammatory biomarkers in preclinical models of short-term doxorubicin-mediated cardiotoxicity: new frontiers in cardioncology? J Cardiovasc Dev Dis. 9(12):423. doi:10.3390/jcdd9120423.
  • Quagliariello V, Berretta M, Buccolo S, Iovine M, Paccone A, Cavalcanti E, Taibi R, Montopoli M, Botti G, Maurea N. 2021. Polydatin reduces cardiotoxicity and enhances the anticancer effects of sunitinib by decreasing pro-oxidative stress, pro-inflammatory cytokines, and NLRP3 inflammasome expression. Front Oncol. 11:680758. doi:10.3389/fonc.2021.680758.
  • Rahnama I, Arabi SM, Chambari M, Bahrami LS, Hadi V, Mirghazanfari SM, Rizzo M, Hadi S, Sahebkar A. 2023. The effect of Spirulina supplementation on lipid profile: GRADE-assessed systematic review and dose-response meta-analysis of data from randomized controlled trials. Pharmacol Res. 193:106802. doi:10.1016/j.phrs.2023.106802.
  • Ramamoorthy A, Premakumari S. 1996. Effect of supplementation of Spirulina on hypercholesterolemic patients. J Food Sci Technol-Mysore. 33:124–127.
  • Rostami HAA, Marjani A, Mojerloo M, Rahimi B, Marjani M. 2022. Effect of spirulina on lipid Profile, glucose and malondialdehyde levels in type 2 diabetic patients. Braz J Pharm Sci. 58:106802. doi:10.1590/s2175-97902022e191140.
  • Sarubin-Fragakis A. 2007. The health professional’s guide to popular dietary supplements. Chicago: American Dietetic Association.
  • Serban M-C, Sahebkar A, Dragan S, Stoichescu-Hogea G, Ursoniu S, Andrica F, Banach M. 2016. A systematic review and meta-analysis of the impact of Spirulina supplementation on plasma lipid concentrations. Clin Nutr. 35(4):842–851. doi:10.1016/j.clnu.2015.09.007.
  • Shah A, Mehta N, Reilly MP. 2008. Adipose inflammation, insulin resistance, and cardiovascular disease. JPEN J Parenter Enteral Nutr. 32(6):638–644. doi:10.1177/0148607108325251.
  • Shah TZ, Ali AB, Jafri SA, Qazi M. 2013. Effect of nicotinic acid (vitamin B3 or niacin) on the lipid profile of diabetic and non–diabetic rats. Pak J Med Sci. 29(5):1259–1264. doi:10.12669/pjms.295.4193.
  • Shariat A, Farhangi MA, Zeinalian R. 2019. Spirulina platensis supplementation, macrophage inhibitory cytokine-1 (MIC-1), oxidative stress markers and anthropometric features in obese individuals: a randomized controlled trial. J Herbal Med. 17-18:100264. doi:10.1016/j.hermed.2019.100264.
  • Sharma NK, Tiwari SP, Tripathi K, Rai AK. 2011. Sustainability and cyanobacteria (blue-green algae): facts and challenges. J Appl Phycol. 23(6):1059–1081. doi:10.1007/s10811-010-9626-3.
  • Skrypnik K, Suliburska J, Skrypnik D, Pilarski Ł, Reguła J, Bogdański P. 2017. The genetic basis of obesity complications. Acta Sci Pol Technol Aliment. 16(1):83–91. doi:10.17306/J.AFS.2017.0442.
  • Strasky Z, Zemankova L, Nemeckova I, Rathouska J, Wong RJ, Muchova L, Subhanova I, Vanikova J, Vanova K, Vitek L, et al. 2013. Spirulina platensis and phycocyanobilin activate atheroprotective heme oxygenase-1: a possible implication for atherogenesis. Food Funct. 4(11):1586–1594. doi:10.1039/c3fo60230c.
  • Szulinska M, Gibas-Dorna M, Miller-Kasprzak E, Suliburska J, Miczke A, Walczak-Gałezewska M, Stelmach-Mardas M, Walkowiak J, Bogdanski P. 2017. Spirulina maxima improves insulin sensitivity, lipid profile, and total antioxidant status in obese patients with well-treated hypertension: a randomized double-blind placebo-controlled study. Eur Rev Med Pharmacol Sci. 21(10):2473–2481.
  • Talior I, Tennenbaum T, Kuroki T, Eldar-Finkelman H. 2005. PKC-δ-dependent activation of oxidative stress in adipocytes of obese and insulin-resistant mice: role for NADPH oxidase. Am J Physiol Endocrinol Metab. 288(2):E405–E411. doi:10.1152/ajpendo.00378.2004.
  • Terry MJ, Maines M, Lagarias J. 1993. Inactivation of phytochrome-and phycobiliprotein-chromophore precursors by rat liver biliverdin reductase. J Biol Chem. 268(35):26099–26106. doi:10.1016/S0021-9258(19)74286-0.
  • Tomaselli L. 1997. Morphology, ultrastructure and taxonomy of Arthrospira (Spirulina) maxima and Arthrospira (Spirulina) platensis. In: Avigad Vonshak, editor. Spirulina platensis (Arthrospira): physiology, cell-biology and biotechnology. London: CRC Press. p. 1–16.
  • Ugalde U, Castrillo J. 2002. Single cell proteins from fungi and yeasts. In: George G. Khachatourians, Dilip K. Arora, editors. Applied Mycology and Biotechnology. Vol. 2. Elsevier; p. 123–149.
  • Upasani CD, Balaraman R. 2003. Protective effect of Spirulina on lead induced deleterious changes in the lipid peroxidation and endogenous antioxidants in rats. Phytother Res. 17(4):330–334. doi:10.1002/ptr.1135.
  • Wang Y, Wang S, Harvat T, Kinzer K, Zhang L, Feng F, Qi M, Oberholzer J. 2015. Diazoxide, a K(ATP) channel opener, prevents ischemia-reperfusion injury in rodent pancreatic islets. Cell Transplant. 24(1):25–36. doi:10.3727/096368913x673441.
  • Wells ML, Potin P, Craigie JS, Raven JA, Merchant SS, Helliwell KE, Smith AG, Camire ME, Brawley SH. 2017. Algae as nutritional and functional food sources: revisiting our understanding. J Appl Phycol. 29(2):949–982. doi:10.1007/s10811-016-0974-5.
  • Westerbacka J, Lammi K, Häkkinen A-M, Rissanen A, Salminen I, Aro A, Yki-Järvinen H. 2005. Dietary fat content modifies liver fat in overweight nondiabetic subjects. J Clin Endocrinol Metab. 90(5):2804–2809. doi:10.1210/jc.2004-1983.
  • Westphal SA, Gannon MC, Nuttall FQ. 1990. Metabolic response to glucose ingested with various amounts of protein. Am J Clin Nutr. 52(2):267–272. doi:10.1093/ajcn/52.2.267.
  • World Health Organization. 2022. Noncommunicable diseases (NCDs) - fact sheet. https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases.
  • Wu JM, Hsieh TC. 2011. Resveratrol: a cardioprotective substance. Ann N Y Acad Sci. 1215(1):16–21. doi:10.1111/j.1749-6632.2010.05854.x.
  • Yang Y, Du L, Hosokawa M, Miyashita K. 2020. Spirulina lipids alleviate oxidative stress and inflammation in mice fed a high-fat and high-sucrose diet. Mar Drugs. 18(3):148. doi:10.3390/md18030148.
  • Yousefi R, Mottaghi A, Saidpour A. 2018. Spirulina platensis effectively ameliorates anthropometric measurements and obesity-related metabolic disorders in obese or overweight healthy individuals: a randomized controlled trial. Complement Ther Med. 40:106–112. doi:10.1016/j.ctim.2018.08.003.
  • Zarezadeh M, Faghfouri AH, Radkhah N, Foroumandi E, Khorshidi M, Rasouli A, Zarei M, Mohammadzadeh Honarvar N, Hazhir Karzar N, Ebrahimi Mamaghani M. 2021. Spirulina supplementation and anthropometric indices: a systematic review and meta-analysis of controlled clinical trials. Phytother Res. 35(2):577–586. doi:10.1002/ptr.6834.
  • Zeinalian R, Farhangi MA, Shariat A, Saghafi-Asl M. 2017. The effects of Spirulina Platensis on anthropometric indices, appetite, lipid profile and serum vascular endothelial growth factor (VEGF) in obese individuals: a randomized double blinded placebo controlled trial. BMC Complement Altern Med. 17(1):225. doi:10.1186/s12906-017-1670-y.
  • Zheng J, Inoguchi T, Sasaki S, Maeda Y, McCarty MF, Fujii M, Ikeda N, Kobayashi K, Sonoda N, Takayanagi R. 2013. Phycocyanin and phycocyanobilin from Spirulina platensis protect against diabetic nephropathy by inhibiting oxidative stress. Am J Physiol Regul Integr Comp Physiol. 304(2):R110–R120. doi:10.1152/ajpregu.00648.2011.